针对1型糖尿病青少年的基于正念的小组干预:试点和可行性随机对照试验的初步发现
Molly Basch1,2, Francesca Lupini1, Sally Ho1
1Center for Translational Research, Children's National Hospital, Washington, DC, United States.
Journal of pediatric psychology
|August 30, 2024
概括
基于虚拟的正念干预 (MBI) 和健康教育 (HE) 对1型糖尿病 (T1D) 的青少年来说是可行的和可以接受的. 两组都在心理健康和血糖控制方面表现出改善,趋势有利于MBI.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 行为医学是一种行为医学.
- 临床心理学 临床心理学
背景情况:
- 青少年的1型糖尿病 (T1D) 管理存在独特的心理社会挑战.
- 基于正念的干预措施 (MBI) 显示出改善心理健康和福祉的前景.
- 虚拟交付格式为儿科干预提供了可访问的选择.
研究的目的:
- 评估为患有T1D的青少年量身定制的虚拟群体正念干预 (MBI) 的可行性和可接受性.
- 将MBI组与健康教育 (HE) 控制组进行比较.
主要方法:
- 一个双向受控试验随机选择了T1D患有MBI或HE的青少年 (12-17岁) 6-7周.
- 可行性通过招聘,保留和出席率来衡量.
- 通过会议后的调查来评估可接受性;心理社会和血糖结果在基线,计划后和3个月后续测量.
主要成果:
- 观察到高的资格率 (55%),入学率 (100%),留学率 (93%) 和出席率 (96%).
- 无论是MBI和HE组都报告了高的会议享受和帮助力.
- 这两组都显示了抑郁,焦虑,饮食失调,糖尿病困扰和HbA1c的减少,趋势表明MBI的益处更大.
结论:
- 虚拟MBI和HE干预对于T1D青少年来说是可行的和可以接受的.
- 初步证据表明,心理社会,行为和糖尿病特异性结果的潜在改善.
- 需要进一步的疗效试验来证实MBI在改善青少年T1D的负面影响和血糖控制方面的有效性.
相关概念视频
Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K


